A phase II study of 18F-fluorodeoxyglucose PET–CT in non-small cell lung cancer patients receiving erlotinib (Tarceva®); objective and symptomatic responses at 6 and 12weeks

2012 ◽  
Vol 48 (1) ◽  
pp. 68-74 ◽  
Author(s):  
M.E.R. O’Brien ◽  
J.S. Myerson ◽  
J.I.G. Coward ◽  
M. Puglisi ◽  
L. Trani ◽  
...  
2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 7549-7549 ◽  
Author(s):  
C. Reynolds ◽  
A. I. Spira ◽  
W. L. Gluck ◽  
R. E. Pluenneke ◽  
K. A. Boehm ◽  
...  

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e20596-e20596
Author(s):  
Kaname Nosaki ◽  
Yoshimasa Shiraishi ◽  
Fumihiko Hirai ◽  
Taishi Harada ◽  
Daisuke Himeji ◽  
...  

Chemotherapy ◽  
2013 ◽  
Vol 59 (6) ◽  
pp. 414-419 ◽  
Author(s):  
Young Hak Kim ◽  
Takashi Nishimura ◽  
Hiroaki Ozasa ◽  
Hiroki Nagai ◽  
Yuichi Sakamori ◽  
...  

1993 ◽  
Vol 29 (12) ◽  
pp. 1720-1722 ◽  
Author(s):  
J. Jassem ◽  
H. Karnicka-Młodkowska ◽  
Ch. van Pottelsberghe ◽  
M. van Glabbeke ◽  
M.A. Noseda ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document